BSE:524412 - Aarey Drugs & Pharmaceuticals Ltd. Aarey Drugs & Pharmaceuticals
Sector: Health Care, Industry: Pharmaceuticals
Add to Watchlist
   
Add Alert 


Yahoo Finance | Screener.in

INR 48.8    -0.48 (-0.97%)

12 Apr 2024


Loading...
Loading...
Loading...

General

CEO: Mr. Mihir Rajesh Ghatalia

Headquarters: IN

Employees: 0

Homepage

Description

Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, bulk drugs, intermediates, and specialty chemicals for various industrial applications in India. The company offers mono methyl and dimethyl urea, theobromine, mefanamic acid, bromomethyl, and dioxolane. It also offers chemicals and solvents, which include aeromatics chemicals, chemical acids, chlor alkalies, glycols and glycol ethers, fiber intermediates, acetates and esters, and chlorinated solvents, as well as industrial alchols, ketones, amines, oleochemicals, intermediates, olefines, phosphates, fertilizers, monomers, and chemicals. The company's pharmaceutical products are used by pharmaceutical formulation manufacturers and pharmaceutical merchant exporters. It also trades in industrial solvents and chemicals. The company was formerly known as Niharika Textiles & Chemicals Private Limited and changed its name to Aarey Drugs & Pharmaceuticals Limited in March 1993. Aarey Drugs & Pharmaceuticals Limited was incorporated in 1990 and is headquartered in Mumbai, India.

Screener.in

Your Holdings
Dashboard
Portfolio
Options

Tools
Screener
Watchlist
Alerts
Notes
Community
Forum
Blog
YouTube
Shared Portfolios
Shared Screeners

Collab with Brokerages
Moomoo x StocksCafe
Tiger x StocksCafe

Help
Quickstart Guides
StocksCafe Academy
StocksCafe Youtube Channel

About StocksCafe
Our Story
Send Feedback
Pricing
Market
Singapore
Hong Kong
Tokyo
Kuala Lumpur
United States
London
Shenzhen
Shanghai
National (India)
Indexes
Singapore Savings Bonds
Singapore T-Bills
CoinGecko
Your Account
Settings
Subscriptions
Referrals
Messages
Profile
YouTube
Server T1

About · FAQs · StocksCafe © 2024 · Privacy · Terms